Luis Vallina-Alvarez
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Generation and functional evaluation of STAb-T cells.
Journal: Methods in cell biology
Published: January 31, 2026
A Drug-Gated, Modular STAb-T Immunotherapy With External Control.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 22, 2026
Anti-angiogenic therapies in cancer: from endogenous inhibitors to bispecific VEGF x PD-(L)1 antibodies.
Journal: Frontiers in immunology
Published: October 31, 2025
Simultaneous secretion of a PD-L1 x 4-1BB bispecific antibody improves antileukemic efficacy of STAb-T cells secreting a CD19-specific T-cell engager.
Journal: Oncoimmunology
Published: October 27, 2025
Generation and functional evaluation of bispecific T cell engaging antibodies.
Journal: Methods in cell biology
Published: October 17, 2025
mRNA-engineered T lymphocytes secreting bispecific T cell engagers with therapeutic potential in solid tumors.
Journal: Frontiers in immunology
Published: August 12, 2025
Bispecific antibodies and nanotechnology: a strategic alliance in cancer immunotherapy.
Journal: Molecular cancer
Published: June 30, 2025
CD22 CAR-T cells secreting CD19 T-cell engagers for improved control of B-cell acute lymphoblastic leukemia progression.
Journal: Journal for immunotherapy of cancer
Published: April 07, 2025
Effective cancer immunotherapy combining mRNA-encoded bispecific antibodies that induce polyclonal T cell engagement and PD-L1-dependent 4-1BB costimulation.
Journal: Frontiers in immunology
Published: September 10, 2024
CD4+ tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts.
Journal: Oncoimmunology
Published: August 29, 2024
Last Updated: 09/26/2026